Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.6200 (0.36%) ($5.6200 - $5.6200) on Wed. Oct. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.88% (three month average) | RSI | 40 | Latest Price | $5.6200(0.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.9% a day on average for past five trading days. | Weekly Trend | AUTL declines -3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(53%) ARKG(49%) IBUY(49%) ARKK(48%) IWO(48%) | Factors Impacting AUTL price | AUTL will decline at least -1.94% in a week (0% probabilities). VIXM(-34%) VXX(-30%) TLT(-24%) SHY(-22%) BNDX(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.94% (StdDev 3.88%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.96(-170.46%) | Resistance Level | $5.98 | 5 Day Moving Average | $5.64(-0.35%) | 10 Day Moving Average | $5.81(-3.27%) | 20 Day Moving Average | $5.98(-6.02%) | To recent high | -23.7% | To recent low | 5.7% | Market Cap | $294m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |